AtriCure, Inc. ATRC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.03% | 12.83% | 14.26% | 13.05% | 15.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.03% | 12.83% | 14.26% | 13.05% | 15.84% |
| Cost of Revenue | 6.57% | 0.92% | 3.05% | 11.07% | 13.12% |
| Gross Profit | 17.78% | 16.90% | 18.01% | 13.73% | 16.75% |
| SG&A Expenses | 5.94% | 5.32% | 11.17% | 8.53% | 6.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.96% | 1.13% | 8.60% | -0.57% | 8.71% |
| Operating Income | 1,992.79% | 256.09% | 108.83% | 117.15% | 102.81% |
| Income Before Tax | 4,770.93% | 258.98% | 106.05% | 115.42% | 98.86% |
| Income Tax Expenses | -125.97% | 80.46% | 19.67% | 127.07% | -43.79% |
| Earnings from Continuing Operations | 1,622.10% | 244.67% | 101.60% | 111.28% | 96.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,622.10% | 244.67% | 101.60% | 111.28% | 96.60% |
| EBIT | 1,992.79% | 256.09% | 108.83% | 117.15% | 102.81% |
| EBITDA | 82.78% | 1,566.41% | 766.55% | 178.35% | 317.08% |
| EPS Basic | 1,583.93% | 241.87% | 101.54% | 111.08% | 96.64% |
| Normalized Basic EPS | 4,763.64% | 255.86% | 105.94% | 115.18% | 98.90% |
| EPS Diluted | 900.00% | 238.46% | 101.54% | 110.87% | 94.00% |
| Normalized Diluted EPS | 4,681.82% | 255.21% | 105.83% | 114.88% | 98.90% |
| Average Basic Shares Outstanding | 2.03% | 1.98% | 1.99% | 1.77% | 1.73% |
| Average Diluted Shares Outstanding | 3.99% | 2.40% | 3.49% | 3.71% | 1.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |